Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer

被引:165
|
作者
Patz, EF
Rossi, S
Harpole, DH
Herndon, JE
Goodman, PC
机构
[1] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Thorac Surg, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Div Biometry Community & Family Med, Durham, NC 27710 USA
关键词
lung cancer; lung cancer screening; pulmonary nodules;
D O I
10.1378/chest.117.6.1568
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: The purpose of this study was to determine the relationship between tumor size and survival in patients with state IA non-small cell lung cancer (non-small cell lung cancer; ie, lesions < 3 cm). Method: Five hundred ten patients with pathologic stage IA (T1N0M0) non-small cell lung cancer were identified from our tumor registry over an 18-year period (from 1981 to 1999). There were 285 men and 225 women, with a mean age of 63 years (range, 31 to 90 years). The Cox proportional model was used to examine the effect on survival. Tumor size was incorporated into the model as a linear effect and as categorial variables. The Kaplan-Meier product limit estimator was used to graphically display the relationship between the tumor size and survival. Results: The Cox proportional hazards model did not show a statistically significant relationship between tumor size and survival (p = 0.701) as a linear effect. Tumor size was then categorized into quartiles, and again there was no statistically significant difference in survival between groups (p = 0.597). Tumor size was also categorized into deciles, and there was no statistical relationship between tumor size and survival (p = 0.674). Conclusions: This study confirms stratifying patients with stage IA non-small cell lung cancer in the same TNM classification, given no apparent difference in survival. Unfortunately, these data caution that improved small nodule detection with screening CT may not significantly improve lung cancer mortality. The appropriate prospective randomized trial appears warranted.
引用
收藏
页码:1568 / 1571
页数:4
相关论文
共 50 条
  • [41] Nomogram Predicting the Prognosis of Patients with Surgically Resected Stage IA Non-small Cell Lung Cancer
    Xu-Feng Deng
    Yin Dai
    Xiao-Qing Liu
    Huang-Zhi Qi
    Dong Zhou
    Hong Zheng
    Jiang Li
    Quan-Xing Liu
    Indian Journal of Surgical Oncology, 2023, 14 : 376 - 386
  • [42] Nomogram Predicting the Prognosis of Patients with Surgically Resected Stage IA Non-small Cell Lung Cancer
    Deng, Xu-Feng
    Dai, Yin
    Liu, Xiao-Qing
    Qi, Huang-Zhi
    Zhou, Dong
    Zheng, Hong
    Li, Jiang
    Liu, Quan-Xing
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2023, 14 (02) : 376 - 386
  • [43] Overuse of Diagnostic Brain Imaging Among Patients With Stage IA Non-Small Cell Lung Cancer
    Milligan, Michael G.
    Cronin, Angel M.
    Colson, Yolonda
    Kehl, Kenneth
    Yeboa, Debra N.
    Schrag, Deborah
    Chen, Aileen B.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (05): : 547 - 554
  • [44] Effectiveness of radiofrequency ablation therapy for patients with unresected Stage IA non-small cell lung cancer
    Li, Ming
    Qin, Yingyi
    Mei, Aihong
    Wang, Changhui
    Fan, Lihong
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (05) : 1007 - +
  • [45] Overuse of Diagnostic Brain Imaging among patients with Stage IA Non-Small Cell Lung Cancer
    Milligan, M.
    Cronin, A. M.
    Li, L.
    Colson, Y.
    Kehl, K.
    Chen, A. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E420 - E421
  • [46] No Prognostic Impact of Staging Brain MRI in Patients with Stage IA Non-Small Cell Lung Cancer
    Nam, Ju G.
    Hong, Hyunsook
    Choi, Seung Hong
    Park, Chang Min
    Goo, Jin Mo
    Kim, Young Tae
    Kim, Hyungjin
    RADIOLOGY, 2022, 303 (03) : 632 - 643
  • [47] Stage IA lung cancer size and survival
    Reich, J
    CHEST, 2004, 126 (01) : 310 - 311
  • [48] The Impact of Surveillance after Lobectomy for Stage IA Non-small Cell Lung Cancer
    Mallipeddi, M. K.
    Eltaraboulsi, W. R.
    Shoffner, A. R.
    Naqvi, I. A.
    D'Amico, T. A.
    Onaitis, M. W.
    Berry, M. F.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S153 - S154
  • [49] Complex Segmentectomy for Hypermetabolic Clinical Stage IA Non-Small Cell Lung Cancer
    Handa, Yoshinori
    Tsutani, Yasuhiro
    Mimae, Takahiro
    Miyata, Yoshihiro
    Ito, Hiroyuki
    Shimada, Yoshihisa
    Nakayama, Haruhiko
    Ikeda, Norihiko
    Okada, Morihito
    ANNALS OF THORACIC SURGERY, 2022, 113 (04): : 1317 - 1324
  • [50] Survival after pathological stage IA nonsmall cell lung cancer:: Tumor size matters
    Birim, Ö
    Kappetein, AP
    Takkenberg, JJM
    van Klaveren, RJ
    Bogers, AJJC
    ANNALS OF THORACIC SURGERY, 2005, 79 (04): : 1137 - 1141